par Abdel Azim, Hatem Hamdy 
;de Azambuja, Evandro ;Agbor-Tarh, Dominique;Bradbury, Ian
Référence Journal of clinical oncology, 32, 30, page (3459)
Publication Publié, 2014-10
;de Azambuja, Evandro ;Agbor-Tarh, Dominique;Bradbury, IanRéférence Journal of clinical oncology, 32, 30, page (3459)
Publication Publié, 2014-10
Lettre à l'éditeur
| Titre: |
|
| Auteur: | Abdel Azim, Hatem Hamdy; de Azambuja, Evandro; Agbor-Tarh, Dominique; Bradbury, Ian |
| Informations sur la publication: | Journal of clinical oncology, 32, 30, page (3459) |
| Statut de publication: | Publié, 2014-10 |
| Sujet CREF: | Généralités |
| MeSH keywords: | Antibodies, Monoclonal, Humanized -- adverse effects |
| Antineoplastic Agents -- adverse effects | |
| Breast Neoplasms -- drug therapy | |
| Diarrhea -- chemically induced | |
| Drug Eruptions -- etiology | |
| Drug-Induced Liver Injury -- etiology | |
| Female | |
| Humans | |
| Neoadjuvant Therapy -- methods | |
| Quinazolines -- adverse effects | |
| Note générale: | SCOPUS: le.j |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0732-183X |
| info:doi/10.1200/JCO.2014.57.0945 | |
| info:pii/JCO.2014.57.0945 | |
| info:scp/84908459727 | |
| info:pmid/25225439 |
